Amended Current Report Filing (8-k/a)
December 30 2020 - 4:32PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
Amendment
No. 1
CURRENT
REPORT
PURSUANT
TO SECTION 13 or 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (date of earliest event reported): October 19, 2020
HealthLynked
Corp.
(Exact Name of Registrant as Specified in its Charter)
Nevada
|
|
47-1634127
|
(State
of Incorporation)
|
|
(I.R.S.
Employer Identification No.)
|
|
|
|
1265
Creekside Parkway, Naples FL
|
|
34108
|
(Address
of Principal Executive Offices)
|
|
(ZIP
Code)
|
(239)
513-1992
(Registrant’s
Telephone Number, Including Area Code)
N/A
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act: None.
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
EXPLANATORY
NOTE
This
Current Report on Form 8-K/A (this “Amendment No. 1”) is being filed to amend and supplement “Item 9.01
– Financial Statements and Exhibits,” included in the initial report on Form 8-K filed by HealthLynked Corp. (the
“Corporation”) on October 21, 2020 (the “Initial Filing”), to include the required audited
and unaudited financial statements of MedOffice Direct LLC (collectively, the “Acquired Subsidiary”),
pursuant to Rule 3-05(b) of Regulation S-X, and the unaudited pro forma consolidated financial statements for the consolidated
Corporation and Acquired Subsidiary pursuant to Article 11 of Regulation S-X. The required audited and unaudited consolidated
financial statements and unaudited pro forma consolidated financial statements are filed as exhibits to this report under Item
9.01.
The
information previously reported on the Initial Filing is incorporated by reference into this Amendment No. 1. The other items
to the Initial Filing further remain unchanged and are not amended hereby.
Item
9.01. Financial Statements and Exhibits.
(a)
Financial Statements of Businesses Acquired. The audited financial statements of the Acquired Subsidiary for
the years ended December 31, 2019 and 2018, and the unaudited condensed financial statements for the nine months
ended September 30, 2020 and 2019, including the notes to such financial statements and the report of independent auditors thereon,
are filed as Exhibit 99.1 to this Current Report on Form 8-K/A and incorporated into this Item 9.01(a) by reference.
(b)
Pro Forma Financial Information. The pro forma financial information required by this item is filed as Exhibit 99.2 to
this Form 8-K/A.
(d) Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HEALTHLYNKED
CORP.
|
|
|
Dated:
December 30, 2020
|
/s/
George O’Leary
|
|
George
O’Leary
|
|
Chief
Financial Officer
|
2
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Aug 2024 to Sep 2024
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Sep 2023 to Sep 2024